{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:09:47Z","timestamp":1774080587064,"version":"3.50.1"},"reference-count":48,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"abstract":"<jats:p>Psoriasis is a chronic, immune-mediated skin disease that impacts the lives and well-being of many patients. Although current therapies are largely centered around immunosuppression and immune-modulation, emerging evidence suggests that glucagon-like peptide-1 (GLP-1) receptor agonists, commonly used in the treatment of type 2 diabetes mellitus and obesity, may have a possible role in the treatment and management of psoriatic inflammation and flares. In this literature review, we aim to synthesize and characterize existing literature discussing the use of GLP-1 receptor agonists in the treatment of psoriasis, evaluate the effectiveness of this therapeutic approach, and highlight limitations in current research. We analyze case reports, cohort studies, and clinical trials to assess clinical outcomes, proposed mechanisms of action, and patient populations. While preliminary evidence supports the use of GLP-1 receptor agonists as an adjunctive treatment for psoriasis, small sample sizes, heterogeneous study designs, variable follow-up times, and the lack of randomized controlled trials emphasize the necessity for further research. Addressing these gaps in research is crucial for defining the role of GLP-1 receptor agonists in the treatment of psoriasis and establishing their potential as an optimistic new therapeutic approach for this chronic inflammatory disease.<\/jats:p>","DOI":"10.1177\/12034754261428062","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:50:22Z","timestamp":1773831022000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Adapting Glucagon-Like Peptide-1 Receptor Agonists for Innovative Psoriasis Therapy"],"prefix":"10.1177","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5357-5737","authenticated-orcid":false,"given":"Erika","family":"Tanquilut","sequence":"first","affiliation":[{"name":"Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7605-3622","authenticated-orcid":false,"given":"Madeleine","family":"Dumke","sequence":"additional","affiliation":[{"name":"Arizona College of Osteopathic Medicine, Midwestern University, Glendale, AZ, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5794-3124","authenticated-orcid":false,"given":"Andres","family":"Parga","sequence":"additional","affiliation":[{"name":"HCA Florida Healthcare\/USF Morsani College of Medicine GME, Brooksville, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mallory","family":"Suhling","sequence":"additional","affiliation":[{"name":"Chicago College of Osteopathic Medicine, Midwestern University, Downers Grove, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelyn","family":"Hunt","sequence":"additional","affiliation":[{"name":"University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailey","family":"Bae","sequence":"additional","affiliation":[{"name":"College of Osteopathic Medicine, California Health Sciences University, Clovis, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2529-8056","authenticated-orcid":false,"given":"Yvonne","family":"Kong","sequence":"additional","affiliation":[{"name":"David Geffen School of Medicine, UCLA, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6808-9174","authenticated-orcid":false,"given":"Kelly","family":"Frasier","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Northwell Health, New Hyde Park, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.04.029"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18044"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00849-3"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2021.11102"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/bor.0b013e3283031c99"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.23736\/s0392-0488.17.05621-8"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1089\/met.2019.0092"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-77914-1"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2018.78028"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1155\/mi.2005.273"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom903009"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2016.1197243"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.02.038"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001538"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594735"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-025-04174-2"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08769.x"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1708853"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12886"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3145-0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1544"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.35841\/aady-8.5.229"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2012.07.086"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4330-3"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1643-x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.03.002"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1826392"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-011-0359-9"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1530\/edm-21-0007"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04609.x"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.01.014"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.09.027"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.19574"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-02969-3"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S485061"},{"key":"e_1_3_2_37_2","unstructured":"Truong A. GLP-1 agonists and psoriasis: a potential novel therapeutic approach. International Psoriasis Council. Published March 25 2025. Accessed July 19 2025. https:\/\/psoriasiscouncil.org\/treatment-guidelines\/glp-1-agonists-and-psoriasis\/"},{"issue":"3","key":"e_1_3_2_38_2","first-page":"42","article-title":"A review of glucagon-like peptide-1 in dermatology","volume":"18","author":"Patino L.","year":"2025","unstructured":"Patino L. A review of glucagon-like peptide-1 in dermatology. J Clin Aesthet Dermatol. 2025;18(3):42-50.","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_3_2_39_2","unstructured":"National Institute of Arthritis and Musculoskeletal and Skin Diseases. Psoriasis. Published June 5 2025. Accessed August 5 2025. https:\/\/www.niams.nih.gov\/health-topics\/psoriasis"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.1774140"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1172\/jci19475141"},{"key":"e_1_3_2_42_2","unstructured":"GLP-1 agonists and psoriatic disease. National Psoriasis Foundation. Published 2025. Accessed August 3 2025. https:\/\/www.psoriasis.org\/advance\/glp-1-agonists-and-psoriatic-disease\/"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1177\/20420188231222367"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216095"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-05323-7"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24097789"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.722"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2015.64"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12629"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754261428062","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754261428062","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754261428062","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:17:27Z","timestamp":1774077447000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/12034754261428062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":48,"alternative-id":["10.1177\/12034754261428062"],"URL":"https:\/\/doi.org\/10.1177\/12034754261428062","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"article-number":"12034754261428062"}}